Related Experiment Video
Updated: Jul 21, 2025

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
Published on: December 13, 2024
Long-Term Use of Amoxicillin Is Associated with Changes in Gene Expression and DNA Methylation in Patients with Low
Maria Dehli Vigeland1,2,3, Siri Tennebø Flåm3, Magnus Dehli Vigeland2,3
1Department of Research, Innovation and Education, Division of Clinical Neuroscience, Oslo University Hospital, 0450 Oslo, Norway.
Abstract:
Long-term antibiotics are prescribed for a variety of medical conditions, recently including low back pain with Modic changes. The molecular impact of such treatment is unknown. We conducted longitudinal transcriptome and epigenome analyses in patients (n = 100) receiving amoxicillin treatment or placebo for 100 days in the Antibiotics in Modic Changes (AIM) study. Gene expression and DNA methylation were investigated at a genome-wide level at screening, after 100 days of treatment, and at one-year follow-up. We identified intra-individual longitudinal changes in gene expression and DNA methylation in patients receiving amoxicillin, while few changes were observed in patients receiving placebo. After 100 days of amoxicillin treatment, 28 genes were significantly differentially expressed, including the downregulation of 19 immunoglobulin genes. At one-year follow-up, the expression levels were still not completely restored. The significant changes in DNA methylation (n = 4548 CpGs) were mainly increased methylation levels between 100 days and one-year follow-up. Hence, the effects on gene expression occurred predominantly during treatment, while the effects on DNA methylation occurred after treatment. In conclusion, unrecognized side effects of long-term amoxicillin treatment were revealed, as alterations were observed in both gene expression and DNA methylation that lasted long after the end of treatment.
Insights
Long-term amoxicillin treatment for Modic changes alters gene expression and DNA methylation. These molecular changes persist long after treatment cessation, indicating potential unrecognized side effects.
Area of Science:
- Molecular biology
- Genomics
- Microbiome research
Background:
- Long-term antibiotic use is increasing for conditions like low back pain with Modic changes.
- The molecular consequences of prolonged antibiotic therapy remain largely unknown.
- Investigating these effects is crucial for understanding treatment safety and efficacy.
Purpose of the Study:
- To investigate the longitudinal molecular impact of 100-day amoxicillin treatment versus placebo on gene expression and DNA methylation.
- To identify changes in transcriptome and epigenome in patients with Modic changes.
- To assess the persistence of these molecular alterations post-treatment.
Main Methods:
- Longitudinal transcriptome and epigenome-wide analyses in 100 patients over 100 days of amoxicillin or placebo.
- Genome-wide gene expression and DNA methylation profiling at screening, day 100, and one-year follow-up.
- Intra-individual analysis to track changes within patients.
Main Results:
- Amoxicillin treatment led to significant intra-individual changes in gene expression and DNA methylation, unlike placebo.
- 28 genes were differentially expressed after 100 days, including downregulated immunoglobulin genes.
- Significant DNA methylation changes (4548 CpGs) were observed, primarily increased methylation post-treatment, with lasting effects on gene expression.
Conclusions:
- Long-term amoxicillin treatment induces significant, lasting molecular alterations in gene expression and DNA methylation.
- These changes suggest unrecognized side effects of prolonged antibiotic use.
- Further research is needed to understand the clinical implications of these persistent molecular changes.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Development of Antibiotic Resistance

![Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58491.jpg&w=3840&q=50)